Study Status: Withdrawn
Recruit Status: Unknown status
Study Type: Interventional
Official Title: The Study for New Effect of Roxithromycin on Androgenetic Alopecia.
Brief Summary: The purpose of this study is exploiting the new drugs for androgenetic alopecia because there are still no effective and safe topical drug for androgenetic alopecia. Roxithomycin is one of the macrolide antibiotics that has immunomodulatory effects. We firstly found that roxithromycin increases the rate of murine and human hair follicle elongation in vitro. Therefore, we apply this drug on this disease therapy.